Allogene Therapeutics (ALLO) Tax Rate (2018 - 2019)
Allogene Therapeutics' (ALLO) quarterly Tax Rate came in at 0.25% in Q4 2019, down 13.0% year-on-year from 0.29% in Q4 2018, and up 489.22% quarter-over-quarter from 0.07% in Q3 2019.
Allogene Therapeutics (ALLO) Tax Rate (2018 - 2019) Analysis & Trends
Allogene Therapeutics has disclosed Tax Rate across 2 years of filings, most recently posting 0.25% for Q4 2019.
- Tax Rate for Q4 2019 came in at 0.25%, down 13.0% year-over-year; the trailing twelve-month figure through Sep 2020 was 0.06% (down 15.0% YoY), and the FY2024 annual result was 0.17%, changed N/A from the prior year.
- Tax Rate came in at 0.25% for Q4 2019 at Allogene Therapeutics, up from 0.07% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 0.48% in Q2 2019 to a low of 0.07% in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -57.14 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -6.79 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 5.61 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 17.68 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Allogene Therapeutics | 482.98 Mn | 482.98 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 0.25% |
| Dec 31, 2019 | 0.25% |
| Sep 30, 2019 | -0.07% |
| Sep 30, 2019 | -0.07% |
| Jun 30, 2019 | 0.48% |
| Jun 30, 2019 | 0.48% |
| Mar 31, 2019 | 0.16% |
| Mar 31, 2019 | 0.16% |
| Dec 31, 2018 | 0.38% |
| Dec 31, 2018 | 0.38% |